JP2015519403A5 - - Google Patents

Download PDF

Info

Publication number
JP2015519403A5
JP2015519403A5 JP2015517461A JP2015517461A JP2015519403A5 JP 2015519403 A5 JP2015519403 A5 JP 2015519403A5 JP 2015517461 A JP2015517461 A JP 2015517461A JP 2015517461 A JP2015517461 A JP 2015517461A JP 2015519403 A5 JP2015519403 A5 JP 2015519403A5
Authority
JP
Japan
Prior art keywords
region
controlled release
mucosa
release polymer
mucoadhesive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015517461A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015519403A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/045976 external-priority patent/WO2013188819A2/en
Publication of JP2015519403A publication Critical patent/JP2015519403A/ja
Publication of JP2015519403A5 publication Critical patent/JP2015519403A5/ja
Pending legal-status Critical Current

Links

JP2015517461A 2012-06-14 2013-06-14 活性剤送達のための粘膜付着性デバイス Pending JP2015519403A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261659781P 2012-06-14 2012-06-14
US201261659784P 2012-06-14 2012-06-14
US61/659,784 2012-06-14
US61/659,781 2012-06-14
US201261671287P 2012-07-13 2012-07-13
US61/671,287 2012-07-13
PCT/US2013/045976 WO2013188819A2 (en) 2012-06-14 2013-06-14 Mucoadhesive devices for delivery of active agents

Publications (2)

Publication Number Publication Date
JP2015519403A JP2015519403A (ja) 2015-07-09
JP2015519403A5 true JP2015519403A5 (cg-RX-API-DMAC7.html) 2016-07-14

Family

ID=48748504

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015517461A Pending JP2015519403A (ja) 2012-06-14 2013-06-14 活性剤送達のための粘膜付着性デバイス

Country Status (5)

Country Link
US (4) US20150174076A1 (cg-RX-API-DMAC7.html)
EP (1) EP2861220A2 (cg-RX-API-DMAC7.html)
JP (1) JP2015519403A (cg-RX-API-DMAC7.html)
CA (1) CA2915358A1 (cg-RX-API-DMAC7.html)
WO (1) WO2013188819A2 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3191083T3 (pl) * 2014-09-11 2021-07-12 Gelita Ag Cząstki żelatyny/pektyny
ES2630106T3 (es) 2014-10-07 2017-08-18 Cyprumed Gmbh Formulaciones farmacéuticas para la administración oral de fármacos peptídicos o proteicos
CN108135962A (zh) 2015-10-07 2018-06-08 塞浦路迈德有限责任公司 用于口服递送肽类药物的药物制剂
US20200030242A1 (en) * 2016-02-05 2020-01-30 Entrega Inc. Oral dosage form with drying agent for delivery of active agent
WO2017143294A1 (en) 2016-02-18 2017-08-24 Privo Technologies, Inc. Two-stage microparticle-based therapeutic delivery system and method
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
WO2018065634A1 (en) 2016-10-07 2018-04-12 Cyprumed Gmbh Pharmaceutical compositions for the nasal delivery of peptide or protein drugs
RU2019125715A (ru) 2017-01-23 2021-02-24 Афикс Терапьютикс А/С Способ изготовления двухслойного продукта на основе электроспряденных волокон
WO2018151849A1 (en) * 2017-02-17 2018-08-23 Privo Technologies, Inc. Particle-based multi-layer therapeutic delivery device and method
US10478403B1 (en) 2017-05-03 2019-11-19 Privo Technologies, Inc. Intraoperative topically-applied non-implantable rapid release patch
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
CN110891646B (zh) 2017-05-17 2023-07-04 麻省理工学院 具有高api载量的组件
CN110809464A (zh) * 2017-06-27 2020-02-18 株式会社培旺精廉宅 粘膜附着性口服制剂
US20210087250A1 (en) 2018-04-06 2021-03-25 Cyprumed Gmbh Pharmaceutical compositions for the transmucosal delivery of therapeutic peptides and proteins
CA3100710A1 (en) 2018-05-17 2019-11-21 Massachusetts Institute Of Technology Systems for electrical stimulation
JP2022523121A (ja) 2019-02-01 2022-04-21 マサチューセッツ インスティテュート オブ テクノロジー 液体注入のためのシステムおよび方法
JP2022544239A (ja) * 2019-08-12 2022-10-17 マサチューセッツ インスティテュート オブ テクノロジー 治療薬の投与のための物品及び方法
US11793980B2 (en) 2019-08-31 2023-10-24 Celero Systems, Inc. Intestinal attachment device
US11541216B2 (en) 2019-11-21 2023-01-03 Massachusetts Institute Of Technology Methods for manufacturing tissue interfacing components
WO2022049310A1 (en) 2020-09-07 2022-03-10 Cyprumed Gmbh Improved pharmaceutical formulations of glp-1 receptor agonists
MX2023010744A (es) 2021-03-15 2023-11-28 Epitomee Medical Ltd Dispositivos expandibles para la administracion de agentes activos a tejidos.
JP2025508982A (ja) 2022-03-03 2025-04-10 サイプルメド ゲーエムベーハー 治療用ペプチドおよびタンパク質の改善された経口医薬製剤
WO2024062466A1 (en) 2022-09-21 2024-03-28 Epitomee Medical Ltd. Controllably disintegrable self-expandable ingestible devices

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56100714A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
US5766620A (en) * 1995-10-23 1998-06-16 Theratech, Inc. Buccal delivery of glucagon-like insulinotropic peptides
US6159497A (en) * 1998-10-30 2000-12-12 Noven Pharmaceuticals, Inc. Patch applicator
AU2002319653A1 (en) * 2001-07-20 2003-03-03 Samir Mitragotri Method for oral drug delivery
MXPA04007584A (es) * 2002-02-07 2004-12-06 Wisconsin Alumni Res Found Compuestos de poliamina y composiciones para su uso en conjunto con una terapia contra el cancer.
CA2533592C (en) * 2003-07-23 2015-11-10 Pr Pharmaceuticals, Inc. Controlled release compositions
US9522188B2 (en) * 2005-12-13 2016-12-20 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
AU2007245265A1 (en) * 2006-05-02 2007-11-08 Panacea Biotec Ltd Transmucosal composition
JP5005422B2 (ja) * 2007-05-09 2012-08-22 株式会社エンプラス 射出成形ギヤ
BR112013011942A2 (pt) * 2010-11-15 2016-11-01 Univ Michigan formulação, forma de dosagem de droga para administração transmucosa oral, sistema transmucoso de fornecimento de droga, método de tratamento e profilaxia de uma doença ou distúrbio, método de tratamento, formulação, método para tratamento ou prevenção de carcinoma de célula escamosa de cabeça e pescoço (hnscc), método para quimioprevenção de um câncer oral ou condição pré-cancerosa, método para aumentar a concentração de uma composição de retinida, método de tratamento e profilaxia de uma doença ou condição, método de ratamento de um sujeito apresentando uma condição médica sintomática, método de tratamento de um câncer oral ou condição pré-cancerosa num paciente, método para fazer um sistema de fornecimento de droga bucal, método para aumentar a liberação e permeação de uma composição de retinida.
US20140017296A1 (en) * 2011-04-04 2014-01-16 Coloplast A/S Adhesive Patch

Similar Documents

Publication Publication Date Title
JP2015519403A5 (cg-RX-API-DMAC7.html)
HK1219096A1 (zh) 抗篡改的药物制剂
AR090218A1 (es) Formulaciones de liberacion inmediata resistentes a la manipulacion
MX2014011626A (es) Peliculas de capas multiples capaces de liberar ingredientes activos por un periodo limitado de tiempo.
RU2700926C2 (ru) Трансдермальные системы, предотвращающие злоупотребление и неправильное употребление
JP2012085643A5 (cg-RX-API-DMAC7.html)
WO2014102613A3 (en) Device for disposal and neutralization of pharmaceutical agents
CN110035744A (zh) 一种尼拉帕尼缓控释药物组合物及其用途
JP2014528431A5 (cg-RX-API-DMAC7.html)
PE20190105A1 (es) Formas de dosificacion de liberacion modificada disuasivas de abuso
PE20142035A1 (es) Formulacion compuesta que comprende un comprimido esferoidal de multiples unidades (must) encapsulada en una capsula dura y metodo para preparar la misma
WO2006023286A3 (en) Controlled release nanoparticle active agent formulation dosage forms and methods
CO6400184A2 (es) Formulaciones galénicas de compuestos orgánicos
EP3556369A4 (en) PROLONGED-RELEASE ORAL PHARMACEUTICAL COMPOSITION OF OLAPARIB AND USES THEREOF
CR20150077A (es) Composición farmacéutica oral en forma de microesferas y proceso de elaboración
JP2014526519A5 (cg-RX-API-DMAC7.html)
WO2014130553A3 (en) Tablet dosage form comprising ritonavir and lopinavir
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
JP2014514104A5 (cg-RX-API-DMAC7.html)
JP2015508411A5 (cg-RX-API-DMAC7.html)
WO2012092486A3 (en) Modified release benzimidazole formulations
JP2008510713A5 (cg-RX-API-DMAC7.html)
JP2012223563A5 (cg-RX-API-DMAC7.html)
WO2017123315A3 (en) Nanocrystals formed in a microenvironment
Velmurugan et al. Mucoadhesive microspheres-a promising carrier in drug delivery: A review